Khylyuk, D.; Holota, S.; Finiuk, N.; Stoika, R.; Rumynska, T.; Lesyk, R.
Design and Optimization of Spiro-Isatin-Thiazolidinone Hybrids with Promising Anticancer Activity. Pharmaceuticals 2025, 18, 1502.
https://doi.org/10.3390/ph18101502
AMA Style
Khylyuk D, Holota S, Finiuk N, Stoika R, Rumynska T, Lesyk R.
Design and Optimization of Spiro-Isatin-Thiazolidinone Hybrids with Promising Anticancer Activity. Pharmaceuticals. 2025; 18(10):1502.
https://doi.org/10.3390/ph18101502
Chicago/Turabian Style
Khylyuk, Dmytro, Serhii Holota, Natalia Finiuk, Rostyslav Stoika, Tetyana Rumynska, and Roman Lesyk.
2025. "Design and Optimization of Spiro-Isatin-Thiazolidinone Hybrids with Promising Anticancer Activity" Pharmaceuticals 18, no. 10: 1502.
https://doi.org/10.3390/ph18101502
APA Style
Khylyuk, D., Holota, S., Finiuk, N., Stoika, R., Rumynska, T., & Lesyk, R.
(2025). Design and Optimization of Spiro-Isatin-Thiazolidinone Hybrids with Promising Anticancer Activity. Pharmaceuticals, 18(10), 1502.
https://doi.org/10.3390/ph18101502